We are live on ! Find out more
NM

Newtyn Management Portfolio holdings

AUM $936M
1-Year Est. Return 27.23%
This Fund
S&P 500
This Quarter Est. Return
-5.2%
1 Year Est. Return
+27.23%
3 Year Est. Return
+51.99%
5 Year Est. Return
+55.23%
10 Year Est. Return
+165.15%
AUM
$405M
AUM Growth
-$18.1M
Cap. Flow
+$17M
Cap. Flow %
4.2%
Top 10 Hldgs %
67.31%
Holding
51
New
5
Increased
22
Reduced
10
Closed
5

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 28.37%
2 Healthcare 23.68%
3 Communication Services 11.57%
4 Technology 9.35%
5 Financials 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNNE icon
1
Cannae Holdings
CNNE
$647M
$53.5M 13.2%
2,868,411
+857,748
+43% +$16.9M
PPLI
2
People Inc
PPLI
$3.1B
$46.9M 11.57%
1,133,670
+36,570
+3% +$1.77M
PAR icon
3
PAR Technology
PAR
$637M
$37.9M 9.35%
982,527
+82,527
+9% +$3.12M
MACK
4
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$23.1M 5.7%
1,873,694
AMBP icon
5
Ardagh Metal Packaging
AMBP
$2.86B
$22.5M 5.55%
7,188,138
+188,138
+3% +$661K
GIII icon
6
G-III Apparel Group
GIII
$1.47B
$20.4M 5.04%
818,816
-826,636
-50% -$17.7M
SPB icon
7
Spectrum Brands
SPB
$2.04B
$19.6M 4.83%
249,937
VTOL icon
8
Bristow Group
VTOL
$1.35B
$19.5M 4.82%
692,896
+18,626
+3% +$539K
TBPH icon
9
Theravance Biopharma
TBPH
$874M
$15.9M 3.92%
1,841,560
+201,104
+12% +$1.94M
CIO
10
DELISTED
City Office REIT
CIO
$13.5M 3.34%
3,180,000
+120,279
+4% +$618K
TSVT
11
DELISTED
2seventy bio
TSVT
$12.1M 2.98%
3,076,490
+2,338,746
+317% +$15.3M
GTX icon
12
Garrett Motion
GTX
$5.9B
$10.5M 2.6%
1,335,572
-146,577
-10% -$1.13M
MBI icon
13
MBIA
MBI
$288M
$10.3M 2.54%
1,425,000
+30,000
+2% +$250K
LKFT
14
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
$9.5M 2.34%
275,000
+5,000
+2% +$195K
BVFL icon
15
BV Financial
BVFL
$177M
$8.86M 2.19%
+879,341
New +$8.71M
CYT
16
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$7.1M 1.75%
2,500,444
+1,142,395
+84% +$3.15M
NODK icon
17
NI Holdings
NODK
$325M
$6.05M 1.49%
470,000
+10,000
+2% +$133K
TLYS icon
18
Tilly's
TLYS
$115M
$5.38M 1.33%
662,247
-137,753
-17% -$1.13M
PFSW
19
DELISTED
PFSweb, Inc.
PFSW
$5.3M 1.31%
711,953
-34,453
-5% -$180K
PHAT icon
20
Phathom Pharmaceuticals
PHAT
$912M
$5.18M 1.28%
500,000
-183,648
-27% -$2.52M
FET icon
21
Forum Energy Technologies
FET
$654M
$4.4M 1.09%
183,300
+3,300
+2% +$82.3K
PCG icon
22
PG&E
PCG
$47.8B
$4.34M 1.07%
268,921
STHO icon
23
Star Holdings Shares of Beneficial Interest
STHO
$112M
$4.09M 1.01%
326,472
+2,000
+0.6% +$27.8K
ASTL icon
24
Algoma Steel
ASTL
$455M
$4.02M 0.99%
590,899
ETNB
25
DELISTED
89bio
ETNB
$3.1M 0.76%
200,500
+500
+0.3% +$8.39K

Similar funds

Newtyn Management's Q3 2023 Portfolio in Review

As of Q3 2023, Newtyn Management held 51 positions worth $405M, down 4.3% from $423M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Newtyn Management deployed $17M of net new capital in Q3 2023, opening 5 new positions and adding to 22 existing holdings. Its largest new stake was BV Financial: 879,341 shares worth $8.86M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was G-III Apparel Group, an estimated $17.7M trimmed.

  • Newtyn Management's largest Q3 2023 buy was BV Financial: 879,341 shares worth $8.86M.
  • Newtyn Management added most to Cannae Holdings in Q3 2023, an estimated $16.9M increase.
  • Newtyn Management's biggest Q3 2023 reduction was G-III Apparel Group, cutting an estimated $17.7M.
  • Newtyn Management fully exited Amplify Energy in Q3 2023, selling an estimated $2.66M.
  • Newtyn Management's ten largest holdings make up 67% of its $405M portfolio in Q3 2023.
  • Newtyn Management opened 5 new positions and closed 5 in Q3 2023.
  • Newtyn Management's portfolio value fell 4.3% quarter-over-quarter to $405M.

Based on Newtyn Management's 13F filing for Q3 2023, filed 14 Nov 2023.